Press Releases Navamedic ASA

Equities

Real-time Oslo Bors Other stock markets 05:21:09 2024-05-13 EDT			5-day change	1st Jan Change
33.1 ^NOK	0.00%		+1.53%	-9.81%

05-06	Navamedic Rolls Out Erectile Dysfunction Drug in Sweden	MT
04-30	Navamedic ASA Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Navamedic ASA: Broad launch for Eroxon® in Sweden today	05-06	AQ
Navamedic ASA: Annual Report 2023	04-30	AQ
Navamedic Q1 2024: Successful product launch and steady operational progress	04-30	AQ
Navamedic ASA: Invitation to 2024 1st quarter presentation	04-23	AQ
Disclosure in NAVAMEDIC ASA	03-21	AQ
Major shareholder disclosure in Navamedic ASA	03-18	AQ
Navamedic ASA - Mandatory notification of trade by primary insider	03-15	AQ
Navamedic ASA: Resolution to increase the share capital in connection with exercise of employee options	03-15	AQ
Navamedic welcomes new shareholders	03-13	AQ
Navamedic ASA - Notification of Major Holdings	03-13	AQ
Navamedic ASA: Notification of major shareholding and mandatory notification of trade	03-12	AQ
Contemplated block sale of existing shares in Navamedic ASA	03-12	AQ
Navamedic ASA: Mandatory notification of trade	02-22	AQ
Navamedic Q4 and full year 2023: A year marked by new records and transformative growth initiatives	02-15	AQ
Navamedic ASA: Invitation to 2023 4th quarter presentation	02-13	AQ
Navamedic ASA launches Eroxon®	02-12	AQ
Navamedic ASA, Renewed contract signed with Vitaflo International Limited	12-22	AQ
Navamedic ASA: Renewed contract signed with Vitaflo International Limited	12-21	AQ
Navamedic and Orion Corporation sign non-binding term sheet for Flexilev® in Europe	12-13	AQ
Navamedic ASA: Record high quarter with above 50 percent growth	11-01	AQ

No results for this search